Sonde Health Raises $19.25 Million Series B to Build the Next Generation of Voice-Based Health Monitoring AI vocal biomarker company will use funding to accelerate its commercial growth, expand its platform into new health conditions, and enter new geographies BOSTON – Dec. 8, 2022 – Sonde Hea.
Stoke Therapeutics to Present Data from the Company's Dravet Syndrome Program at the American Epilepsy Society 2022 Annual Meeting streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
DGAP-News: Adrenomed AG / Key word(s): PersonnelAdrenomed appoints Dr. med. Steffen Stürzebecher as Chief Medical Officer 23.06.2022 / 09:00 The issuer is solely responsible for the content of this announcement.Press ReleaseAdrenomed appoints Dr. med. Steffen Stürzebecher as Chief Medical OfficerHennigsdorf/Berlin (.
/PRNewswire/ Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the addition of a companion.